1. Curcumin- and turmeric-related liver injury

   News item 02 September 2023 Pages: 1 - 1

2. Dr. Berne's recalls eye drops and mist due to contamination

   News item 02 September 2023 Pages: 2 - 2

3. FDA warns against use of OTC products to treat molluscum

   News item 02 September 2023 Pages: 3 - 3

4. Inmar recalls products stored in Arlington facility between May 2022 and June 2023

   News item 02 September 2023 Pages: 4 - 4

5. Medication errors with scopolamine and butylscopolamine

   News item 02 September 2023 Pages: 5 - 5

6. Unauthorised health products seized in Toronto due to health risks

   News item 02 September 2023 Pages: 6 - 6

7. Warning against use of FXSLIM Lady&Man slimming tea

   News item 02 September 2023 Pages: 7 - 7

8. ADRs leading to hospitalisation increase healthcare costs after discharge

   Clinical study 02 September 2023 Pages: 8 - 8

9. Antenatal corticosteroids increase risk of serious infections during infancy

   Clinical study 02 September 2023 Pages: 9 - 9

10. Early antenatal corticosteroids for pregnancies at risk of preterm birth: adverse short- and long-term outcomes

    Review 02 September 2023 Pages: 10 - 10

11. JAK inhibitors may increase risk of skin cancer

    Clinical study 02 September 2023 Pages: 11 - 11

12. Triple therapy as safe as dual therapy for elephantiasis prevention

    Clinical study 02 September 2023 Pages: 12 - 12

13. Other adverse reaction research

    News item 02 September 2023 Pages: 13 - 13

14. Abemaciclib

    Case report 02 September 2023 Pages: 14 - 14

15. Aceclofenac

    Case report 02 September 2023 Pages: 15 - 15

16. Acitretin/leflunomide

    Case report 02 September 2023 Pages: 16 - 16

17. Acitretin/palbociclib/unspecified steroids

    Case report 02 September 2023 Pages: 17 - 17

18. Adalimumab

    Case report 02 September 2023 Pages: 18 - 18

19. Adalimumab

    Case report 02 September 2023 Pages: 19 - 19

20. Adalimumab

    Case report 02 September 2023 Pages: 20 - 20

21. Adalimumab/azathioprine/infliximab

    Case report 02 September 2023 Pages: 21 - 21

22. Adalimumab/ciclosporin/infliximab

    Case report 02 September 2023 Pages: 22 - 22

23. Adalimumab/etanercept

    Case report 02 September 2023 Pages: 23 - 23

24. Adalimumab/secukinumab

    Case report 02 September 2023 Pages: 24 - 24

25. Aflibercept

    Case report 02 September 2023 Pages: 25 - 25

26. Albendazole/azathioprine/unspecified corticosteroids

    Case report 02 September 2023 Pages: 26 - 26

27. Albumin-human/antibacterials/plasma

    Case report 02 September 2023 Pages: 27 - 27

28. Alectinib

    Case report 02 September 2023 Pages: 28 - 28

29. Allantoin/clobetasol/doxepin/doxepin

    Case report 02 September 2023 Pages: 29 - 29

30. Amiodarone

    Case report 02 September 2023 Pages: 30 - 30

31. Amiodarone/hyaluronidase

    Case report 02 September 2023 Pages: 31 - 31

32. Amiodarone/lidocaine

    Case report 02 September 2023 Pages: 32 - 32

33. Amlodipine/benazepril/chlortalidone

    Case report 02 September 2023 Pages: 33 - 33

34. Amlodipine/clonidine/risperidone

    Case report 02 September 2023 Pages: 34 - 34

35. Amoxicillin/ciprofloxacin

    Case report 02 September 2023 Pages: 35 - 35

36. Amoxicillin/clavulanic-acid/AZD-1222/paracetamol

    Case report 02 September 2023 Pages: 36 - 36

37. Amoxicillin/clavulanic-acid/vancomycin

    Case report 02 September 2023 Pages: 37 - 37

38. Amoxicillin/doxycycline

    Case report 02 September 2023 Pages: 38 - 38

39. Amoxicillin/unspecified penicillins

    Case report 02 September 2023 Pages: 39 - 39

40. Amphotericin-B/methylprednisolone/posaconazole

    Case report 02 September 2023 Pages: 40 - 40

41. Amphotericin-b/voriconazole

    Case report 02 September 2023 Pages: 41 - 41

42. Ampicillin/sulbactam

    Case report 02 September 2023 Pages: 42 - 42

43. Anakinra

    Case report 02 September 2023 Pages: 43 - 43

44. Antibacterials

    Case report 02 September 2023 Pages: 44 - 44

45. Antibacterials\micafungin

    Case report 02 September 2023 Pages: 45 - 45

46. Antiepileptic-drugs

    Case report 02 September 2023 Pages: 46 - 46

47. Antineoplastics

    Case report 02 September 2023 Pages: 47 - 47

48. Antineoplastics

    Case report 02 September 2023 Pages: 48 - 48

49. Antineoplastics

    Case report 02 September 2023 Pages: 49 - 49

50. Antineoplastics

    Case report 02 September 2023 Pages: 50 - 50